THE MODE OF ACTION OF COLLOIDAL BISMUTH SUBCITRATE

被引:27
|
作者
LEE, SP [1 ]
机构
[1] VET ADM MED CTR,SEATTLE,WA 98108
关键词
COLLOIDAL BISMUTH SUBCITRATE; CYTOPROTECTION; GASTRODUODENAL DISORDERS; HELICOBACTER-PYLORI; MUCOPROTECTION;
D O I
10.3109/00365529109093213
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colloidal bismuth subcitrate (CBS) is very effective in the treatment of gastroduodenal disorders and appears to act via several mechanisms. It has little acid-neutralizing effect and does not affect acid secretion. It is uncertain whether CBS affects pepsin secretion, but it does inhibit peptic activity. It causes an increase in mucus glycoprotein secretion and may also bind to the gastric mucus layer to act as a diffusion barrier to HCl. CBS accelerates ulcer healing and causes an accumulation of epidermal growth factor around the ulcer. In addition, it has a cytoprotective effect and increases mucosal secretion of prostaglandins and bicarbonate. CBS has bactericidal effects against Helicobacter pylori (which is associated with gastritis and peptic ulcers). It also prevents adhesion of H. pylori to epithelial cells and can inhibit enzymes secreted by H. pylori, such as proteases, lipases, glycosidases, and phospholipases.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [31] ACUTE-RENAL-FAILURE AFTER OVERDOSE OF COLLOIDAL BISMUTH SUBCITRATE
    HUWEZ, F
    PALL, A
    LYONS, D
    STEWART, MJ
    LANCET, 1992, 340 (8830): : 1298 - 1298
  • [32] ENHANCEMENT IN GASTRIC MUCUS GEL QUALITIES WITH COLLOIDAL BISMUTH SUBCITRATE ADMINISTRATION
    PIOTROWSKI, J
    BILSKI, J
    NISHIKAWA, H
    SLOMIANY, A
    SLOMIANY, BL
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 184 (01) : 55 - 63
  • [33] COMBINATION TREATMENT - COLLOIDAL BISMUTH SUBCITRATE WITH H2-ANTAGONISTS
    SALMON, PR
    DIGESTION, 1987, 37 : 42 - 46
  • [34] STUDIES ON THE GASTROPROTECTIVE AND ULCER-HEALING EFFECTS OF COLLOIDAL BISMUTH SUBCITRATE
    KONTUREK, SJ
    RADECKI, T
    PIASTUCKI, I
    DROZDOWICZ, D
    DIGESTION, 1987, 37 : 8 - 15
  • [35] NONULCER DYSPEPSIA AND COLLOIDAL BISMUTH SUBCITRATE THERAPY - THE ROLE OF CAMPYLOBACTER PYLORIDIS
    ROKKAS, T
    PURSEY, C
    SIMMONS, NA
    FILIPE, MI
    SLADEN, GE
    GASTROENTEROLOGY, 1987, 92 (05) : 1599 - 1599
  • [36] Determination of Trimethylbismuth in the Human Body after Ingestion of Colloidal Bismuth Subcitrate
    Boertz, Jens
    Hartmann, Louise Michele
    Sulkowski, Margareta
    Hippler, Joerg
    Mosel, Frank
    Diaz-Bone, Roland Arturo
    Michalke, Klaus
    Rettenmeier, Albert Wolfgang
    Hirner, Alfred Vitalis
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (02) : 352 - 358
  • [37] The protective roles of some lichen species on colloidal bismuth subcitrate genotoxicity
    Geyikoglu, F.
    Turkez, H.
    Aslan, A.
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2007, 23 (08) : 487 - 492
  • [38] Colloidal bismuth subcitrate-induced nephrotoxity: Reversibility and morphology.
    Leussink, BT
    Slikkerveer, A
    Engelbrecht, MRW
    deHeer, E
    vanderVoet, GB
    deWolff, FA
    Bruijn, JA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2817 - A2817
  • [39] Maintenance therapy with colloidal bismuth subcitrate reduces duodenal ulcer relapse
    Bardhan, KD
    Singh, S
    Morris, P
    Thompson, M
    Hinchliffe, RFC
    Cary, BA
    Wall, RM
    Blakemore, CB
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 29 (02): : 128 - 134
  • [40] OMEPRAZOLE AND COLLOIDAL BISMUTH SUBCITRATE INHIBIT HELICOBACTER-PYLORI ATPASE
    BEIL, W
    GASTROENTEROLOGY, 1995, 108 (04) : A58 - A58